| Set | MEDLINE |
|---|---|
| 1 | Bipolar disorder |
| 2 | Bipolar |
| 3 | Manic |
| 4 | Bipolar depression |
| 5 | Manic depressive |
| 6 | Affective psychosis, bipolar |
| 7 | Mania |
| 8 | Manias |
| 9 | Manic depressive psychoses |
| 10 | Bipolar disorder |
| 11 | Sets 1–10 were combined with “OR” |
| 12 | Prevention |
| 13 | Maintenance |
| 14 | Prophylaxys |
| 15 | Long‐term |
| 16 | Continuation |
| 17 | Stabilization |
| 18 | Stability |
| 19 | Combination |
| 20 | Bipolar disorder/prevention and control |
| 21 | Longitudinal studies |
| 22 | Prospective studies |
| 23 | Retrospective studies |
| 24 | Sets 12–23 were combined with “OR” |
| 25 | Lithium AND valproate |
| 26 | Lithium AND divalproex |
| 27 | Lithium AND valproic |
| 28 | Lithium AND lamotrigine |
| 29 | Lithium AND asenapine |
| 30 | Valproate AND lamotrigine |
| 31 | Valproic AND lamotrigine |
| 32 | Divalproex AND lamotrigine |
| 33 | Valproate AND asenapine |
| 34 | Valproic AND asenapine |
| 35 | Divalproex AND asenapine |
| 36 | Lamotrigine AND asenapine |
| 37 | Lamotrigine AND quetiapine |
| 38 | Asenapine AND quetiapine |
| 39 | Aripiprazole AND quetiapine |
| 40 | Asenapine AND aripiprazole |
| 41 | Sets 25–40 were combined with “OR” |
| 42 | Sets 11 and 24 and 41 were combined with “AND” |
| 43 | Set 42 was limited to December 31st, 2019, Humans, English language, Subjects older than 18 years old |
Words written in italic were used as MeSH headings, the others were used as free text.